These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

72 related articles for article (PubMed ID: 26074266)

  • 1. Nicotinic acetylcholine receptors as therapeutic targets: Emerging frontiers in basic research and clinical science--Editorial Comments.
    Dani JA; Donnelly-Roberts D; Bertrand D
    Biochem Pharmacol; 2015 Oct; 97(4):351. PubMed ID: 26074266
    [No Abstract]   [Full Text] [Related]  

  • 2. Nicotinic acetylcholine receptors as therapeutic targets: emerging frontiers in basic research and clinical science--editorial comments.
    Dani JA; Donnelly-Roberts D; Bertrand D
    Biochem Pharmacol; 2013 Oct; 86(8):1041. PubMed ID: 23684691
    [No Abstract]   [Full Text] [Related]  

  • 3. Nicotinic acetylcholine receptors as therapeutic targets: emerging frontiers in basic research and clinical science--Editorial Comments.
    Donnelly-Roberts D; Bertrand D; Gopalakrishnan M
    Biochem Pharmacol; 2011 Oct; 82(8):797. PubMed ID: 21600889
    [No Abstract]   [Full Text] [Related]  

  • 4. Nicotinic acetylcholine receptors as therapeutic targets: emerging frontiers in basic research and clinical science - editorial comments.
    Gopalakrishnan M; Bertrand D; Williams M
    Biochem Pharmacol; 2007 Oct; 74(8):1091. PubMed ID: 17889037
    [No Abstract]   [Full Text] [Related]  

  • 5. Nicotinic acetylcholine receptors as therapeutic targets: emerging frontiers in basic research and clinical science--editorial perspective.
    Bertrand D; Gopalakrishnan M; Donnelly-Roberts D
    Biochem Pharmacol; 2009 Oct; 78(7):657. PubMed ID: 19576180
    [No Abstract]   [Full Text] [Related]  

  • 6. Nicotinic acetylcholine receptor system and neuropsychiatric disorders.
    Singh A; Potter A; Newhouse P
    IDrugs; 2004 Dec; 7(12):1096-103. PubMed ID: 15599803
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Partial agonists as therapeutic agents at neuronal nicotinic acetylcholine receptors.
    Hogg RC; Bertrand D
    Biochem Pharmacol; 2007 Feb; 73(4):459-68. PubMed ID: 16979139
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [A role of alpha-7 nicotinic acetylcholine receptors in pharmacotherapy of neurodegenerative diseases].
    Makotrova TA
    Zh Nevrol Psikhiatr Im S S Korsakova; 2012; 112(10 Pt 2):57-9. PubMed ID: 23250612
    [No Abstract]   [Full Text] [Related]  

  • 9. Brain nicotinic receptors as emerging targets for drug addiction: neurobiology to translational research.
    Rahman S
    Prog Mol Biol Transl Sci; 2011; 98():349-65. PubMed ID: 21199776
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The future of neurodegenerative diseases: emerging targets, treatments and technologies.
    Voss J; Ebert A; Wolfe M; Lindsley C; Cookson M; Deane R
    Future Med Chem; 2012 Sep; 4(13):1661-9. PubMed ID: 22924504
    [No Abstract]   [Full Text] [Related]  

  • 11. Procognitive and neuroprotective activity of a novel alpha7 nicotinic acetylcholine receptor agonist for treatment of neurodegenerative and cognitive disorders.
    Roncarati R; Scali C; Comery TA; Grauer SM; Aschmi S; Bothmann H; Jow B; Kowal D; Gianfriddo M; Kelley C; Zanelli U; Ghiron C; Haydar S; Dunlop J; Terstappen GC
    J Pharmacol Exp Ther; 2009 May; 329(2):459-68. PubMed ID: 19223665
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Neuronal nicotinic acetylcholine receptors as targets for drug discovery.
    Holladay MW; Dart MJ; Lynch JK
    J Med Chem; 1997 Dec; 40(26):4169-94. PubMed ID: 9435889
    [No Abstract]   [Full Text] [Related]  

  • 13. Novel therapeutic strategies in neural diseases uncover unexpected disease connections: from neurodegeneration and addiction to pain and depression.
    Herradón G
    Curr Pharm Des; 2011; 17(5):408-9. PubMed ID: 21375479
    [No Abstract]   [Full Text] [Related]  

  • 14. [Role of smoking and nicotine in neuropsychiatric disorders: evidence for therapeutic role of nicotinic acetylcholine receptors].
    Miyata H
    Nihon Shinkei Seishin Yakurigaku Zasshi; 2008 Aug; 28(4):149-58. PubMed ID: 18800618
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Editorial: Neurodegeneration, Oxidative Stress, Metabolic Syndrome, Drug Design and Development: Clinical Implications.
    Cacabelos R; Reddy VP; Aliev G
    CNS Neurol Disord Drug Targets; 2016; 15(2):126. PubMed ID: 26907796
    [No Abstract]   [Full Text] [Related]  

  • 16. The development of novel polypharmacological agents targeting the multiple binding sites of nicotinic acetylcholine receptors.
    Reyes-Parada M; Iturriaga-Vasquez P
    Expert Opin Drug Discov; 2016 Oct; 11(10):969-81. PubMed ID: 27552487
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Reduced expression of neuronal nicotinic acetylcholine receptors during the early stages of damage by oxidative stress in PC12 cells.
    Guan ZZ; Zhang X; Mousavi M; Tian JY; Unger C; Nordberg A
    J Neurosci Res; 2001 Nov; 66(4):551-8. PubMed ID: 11746374
    [TBL] [Abstract][Full Text] [Related]  

  • 18. From ligand design to therapeutic efficacy: the challenge for nicotinic receptor research.
    Cassels BK; Bermúdez I; Dajas F; Abin-Carriquiry JA; Wonnacott S
    Drug Discov Today; 2005 Dec; 10(23-24):1657-65. PubMed ID: 16376826
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Nicotinic acetylcholine receptors and the regulation of neuronal signalling.
    Dajas-Bailador F; Wonnacott S
    Trends Pharmacol Sci; 2004 Jun; 25(6):317-24. PubMed ID: 15165747
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Editorial: To channel or not to channel? Functioning of nicotinic acetylcholine receptors in leukocytes.
    Skok MV
    J Leukoc Biol; 2009 Jul; 86(1):1-3. PubMed ID: 19567410
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.